At a glance
- Originator Almirall-Prodesfarma
- Class Antihypertensives; Ischaemic heart disorder therapies; Peripheral vasodilators; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris
Most Recent Events
- 16 Sep 1996 Discontinued-Preclinical for Angina pectoris in Spain (Unknown route)
- 29 May 1995 New profile
- 29 May 1995 Preclinical development for Angina pectoris in Spain (Unknown route)